Pancreatic Disorders & Therapy
Open Access

Loyola University Medical Center, Loyola University Chicago Stritch School of Medicine, Maywood, USA

Biography

Asha Dhanarajan is a Hematologist and an Oncologist at All DoD and VA in Maywood, Illinois. Dr. Dhanarajan has been practicing medicine for over 14 years and is highly rated in 15 conditions, according to our data. Her top areas of expertise are Familial Pancreatic Cancer, Cholangiocarcinoma, Fibrolamellar Carcinoma, and Pancreatic Cancer. She is board certified in Hematology/oncology and licensed to treat patients in Illinois. Dr. Dhanarajan is currently accepting new patients. Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 27 clinical trials in the past 15 years.

Publications

• Abstract   
  Adjuvant Systemic Therapy for Intestinal Type Invasive IPMNs: A Case Series and Brief Literature Review
  Author(s): Brian E. Johnson*, Daniel S. Peiffer, Asha Dhanarajan, Ami Badami, Xianzhong Ding and Kenneth Micetich
  
  Intraductal Papillary Mucinous Neoplasms (IPMNs) are epithelial neoplasms that can progress to invasive pancreatic malignancies. While the Sendai guidelines can assist us regarding which IPMNs are likely to be invasive and therefore need resection, there are limited data about management after resection. The adjuvant therapy for resected Invasive IPMNs (I-IPMNs) is currently based off of limited retrospective analyses and expert opinion extrapolating primarily from pancreatic exocrine regimens. The heterogeneity in both pathology and treatment response as seen in a recent systematic review suggests that we should consider delineating between the broad categories of intestinal/colloid type and pancreatobiliary/tubular type I-IPMNs to guide adjuvant systemic therapy similar to what is done with ampullary malignancies. Without prospective studies to guide our treatment decisions, we perf.. View More»
  

  Abstract PDF